ANAlexandre Netto

Alexandre Netto

*This is an algorithmically generated author record based on publicly available information.

Alexandre Netto has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Digital neonatal neurocritical care in Brazil: a retrospective multicentre cohort study of over 11,000 remotely monitored infants

    by Gabriel Fernando Todeschi Variane, Danieli Mayumi Kimura Leandro, Silvia Schoenau de Azevedo, Rafaela Fabri Rodrigues, Leticia Brito Sampaio, Paula Natale Girotto, Maurício Magalhães, Alexandre Netto, Marcelo Jenné Mimica, Valerie Y. Chock, et al.


  • Open Access

    Health care costs during the first 20 years of life in infants with hypoxic-ischemic encephalopathy in Brazil: estimated economic benefits generated by the use of therapeutic hypothermia and brain monitoring / Custos em saúde durante os primeiros 20 anos de vida de lactentes com encefalopatia hipóxico-isquêmica no Brasil: benefícios econômicos estimados gerados pelo uso de hipotermia terapêutica e monitoramento cerebral

    by Gabriel Fernando Todeschi Variane, Alexandre Netto, Daniela Pereira Rodrigues, Danieli Mayumi Kimura Leandro, Carolina Nunes de França, Nathalie Sales Llaguno, Maurício Magalhães, Rafaela Fabri Rodrigues Pietrobom, Teresa Maria Lopes de Oliveira Uras Belém, Marcelo Jenné Mimica

    Background: Hypoxic-ischaemic encephalopathy (HIE) is a leading cause of long-term disability. Infants with HIE may require specific lifelong care, representing a devastating social and economic impact. Therapeutic hypothermia (TH) has been proven to be a safe and effective treatment; however, its potential economic impact associated with continuous electroencephalographic monitoring is still unknown in Brazil. This study aimed to evaluate the potential economic benefits provided by TH and continuous electroencephalographic monitoring in the first 20 years of life in infants with HIE in Brazil. Methods: A resource utilization questionnaire about healthcare of infants with HIE was answered by 57 pediatricians and neonatologists in all five regions of Brazil. This data was used to calculate an annual weighted average of patient management costs according to the presence or degree of disability, considering only directly related health costs. A mathematical calculation was performed considering local incidence of HIE and the number of live births per year. Rates of death and survival for different levels of disability and the effect of TH on these outcomes were estimated from the two most relevant randomized controlled trials on TH. Results: There was an approximately 26-fold increase in spending when the severe disability group was compared to the no disability group (p-value<0.0001, ANOVA-Bonferroni). The estimated total cost of patients with no disability, mild, moderate, and severe disability is US$ 6,808.53, US$ 32,208.43, US$ 105,791.78 and US$ 175,698.58, respectively, and the estimated costs related to the use of TH and neuromonitoring were estimated in US$ 2,824.00. Considering a weighted average between TOBY trial and NICHD trial, it is estimated annual savings of US$ 39,700,000-79,401,000. Conclusions: This study estimated a significant increase in the costs associated with the degree of disability and a positive impact of TH throughout the first 20 years of life. Keywords: Children with disability, Health care costs, Hypoxic-ischemic encephalopathy, Neonatal intensive care, Therapeutic hypothermia Resumo Introdução: A encefalopatia hipóxico-isquêmica (EHI) é uma das principais causas de deficiência incapacitante a longo prazo. Recém-nascidos (RN) com EHI podem necessitar de cuidados específicos ao longo da vida, representando um impacto social e econômico devastador. A hipotermia terapêutica (HT) é comprovadamente um tratamento seguro e eficaz; entretanto, seu potencial impacto econômico associado ao monitoramento eletroencefalográfico contínuo ainda é desconhecido no Brasil. Este estudo tem como objetivo avaliar os potenciais benefícios econômicos proporcionados pela HT e pela monitorização eletroencefalográfica contínua nos primeiros 20 anos de vida em lactentes com EHI no Brasil. Métodos: Um questionário de utilização de recursos sobre cuidados de saúde de crianças com EHI foi respondido por 57 pediatras e neonatologistas das cinco regiões do Brasil. Esses dados foram usados para calcular uma média anual ponderada dos custos de cuidados de saúde destes pacientes de acordo com a presença ou grau de incapacidade, considerando apenas custos de saúde diretos. Um cálculo matemático foi realizado considerando a incidência local de EHI e o número de nascidos vivos por ano. As taxas de mortalidade e de sobrevivência para diferentes níveis de incapacidade e o efeito da HT nestes resultados foram estimados a partir dos dois ensaios clínicos randomizados e controlados mais relevantes sobre a HT. Resultados: Houve um aumento de aproximadamente 26 vezes nos gastos quando o grupo com deficiência grave foi comparado ao grupo sem deficiência (p-valor<0,0001, ANOVA-Bonferroni). O custo total estimado para os pacientes sem incapacidade, com incapacidade leve, moderada e grave é de US$ 6.808,53, US$ 32.208,43, US$ 105.791,78 e US$ 175.698,58, respetivamente, e os custos estimados relacionados ao uso da HT e da neuromonitoramento foram estimados em US$ 2.824,00. Considerando uma média ponderada entre o estudo TOBY e o estudo NICHD, estima-se uma economia anual de US$ 39.700.000-79.401.000. Conclusões: Este estudo estimou um aumento significativo dos custos associados ao grau de incapacidade e um impacto positivo da HT ao longo dos primeiros 20 anos de vida. Palavras-chave: Crianças com deficiência, Custos de cuidados de saúde, Encefalopatia hipóxica-isquêmica, Terapia intensiva neonatal, Hipotermia induzida


  • Open Access

    Protecting brains and saving futures guidelines: A prospective, multicenter, and observational study on the use of telemedicine for neonatal neurocritical care in Brazil

    by Gabriel Fernando Todeschi Variane, Maurício Magalhães, Rafaela Fabri Rodrigues Pietrobom, Alexandre Netto, Daniela Pereira Rodrigues, Renato Gasperini, Guilherme Mendes Sant’anna

    Background: Management of high-risk newborns should involve the use of standardized protocols and training, continuous and specialized brain monitoring with electroencephalography (EEG), amplitude integrated EEG, Near Infrared Spectroscopy, and neuroimaging. Brazil is a large country with disparities in health care assessment and some neonatal intensive care units (NICUs) are not well structured with trained personnel able to provide adequate neurocritical care. To reduce this existing gap, an advanced telemedicine model of neurocritical care called Protecting Brains and Saving Futures (PBSF) Guidelines was developed and implemented in a group of Brazilian NICUs. Methods: A prospective, multicenter, and observational study will be conducted in all 20 Brazilian NICUs using the PBSF Guidelines as standard-of-care. All infants treated accordingly to the guidelines during Dec 2021 to Nov 2024 will be eligible. Ethical approval was obtained from participating centers. The primary objective is to describe adherence to the PBSF Guidelines and clinical outcomes, by center and over a 3-year period. Adherence will be measured by quantification of neuromonitoring, neuroimaging exams, sub-specialties consultation, and clinical case discussions and videoconference meetings. Clinical outcomes of interest are detection of seizures during hospitalization, use of anticonvulsants, inotropes, and fluid resuscitation, death before hospital discharge, length of hospital stay, and referral of patients to specialized follow-up. Discussion: The study will provide evaluation of PBSF Guidelines adherence and its impact on clinical outcomes. Thus, data from this large prospective, multicenter, and observational study will help determine whether neonatal neurocritical care via telemedicine can be effective. Ultimately, it may offer the necessary framework for larger scale implementation and development of research projects using remote neuromonitoring. Trial registration: NCT03786497, Registered 26 December 2018, https://www.clinicaltrials.gov/ct2/show/NCT03786497?term=protecting+brains+and+saving+futures&draw=2&rank=1.


  • Open Access

    Newborns at high risk for brain injury: the role of the amplitude-integrated electroencephalography

    by Gabriel Fernando Todeschi Variane, Daniela Pereira Rodrigues, Rafaela Fabri Rodrigues Pietrobom, Carolina Nunes França, Alexandre Netto, Maurício Magalhães